BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 26, 1998
View Archived Issues
Recent infection: an independent risk factor for acute cerebrovascular ischemia
Read More
MKC-231: a neuroprotective agent with choline uptake and acetylcholine-releasing properties
Read More
Site of spatial short-term memory at last identified in the human brain
Read More
Metadoxine is beneficial in alcoholic patients, even with continued alcohol consumption
Read More
Yamanouchi research yields potential new antipsychotic agents
Read More
Sumitomo scientists describe new agents for hyperlipidemia
Read More
Screening for the BRCA1 mutation is not beneficial in the general female population
Read More
Bosentan reduces blood pressure in patients with essential hypertension
Read More
FDA okays protocol amendments for phase III trial of CBP-1011
Read More
SciClone receives approval to market Zadaxin for hepatitis B in Kuwait
Read More
FDA advisory committee recommends expanded labeling for CEPRATE SC System
Read More
Northwest Hospital's prostate cancer vaccine shows promise in phase I/II; new trial sites added
Read More
Company Profile: Afferon
Read More
Company Profile: Hexagen
Read More
New mechanism identified for Fujisawa antiinflammatory agent
Read More
Differentiation-inducing retinoyloxy(substituted)alkylene butyrates from Bar-Ilan
Read More
Further mechanism-of-action studies conducted on T-614
Read More
Sankyo's kappa-opioid agonist demonstrates potent antinociceptive activity
Read More
Schering AG describes new diagnostics
Read More
Vacuolar ATPase inhibitors claimed by SmithKline Beecham for osteoporosis
Read More
HSR-609: a potent and insurmountable H1 antagonist in vitro
Read More
First report of nonpeptide compounds as MHC class II inhibitors
Read More
New treatments for preterm labor from Merck
Read More
IL-10 in clinical testing for multiple indications at Schering-Plough
Read More
TOBI now available for CF patients with P. aeruginosa
Read More
FDA decides future of pimagedine trials
Read More
FDA to review data from phase III trial of Alferon N Injection in HIV
Read More
Celecoxib copromotion agreement expanded
Read More
Glaxo Wellcome files for European approval of lamivudine in HBV
Read More
